---
title: "Sanofi to acquire Blueprint for up to $9.5B"
date: Mon, 02 Jun 2025 12:06:00 -0400
source: "BioPharmaDive"
link: "https://www.biopharmadive.com/news/sanofi-blueprint-medicines-acquisition-deal-immunology/749557/"
---

<figure><div><img src="https://imgproxy.divecdn.com/FBR1IQNmU9Hqatva496Zg2G8JMHsqV0UGsf4LMARqYo/g:nowe:189:144/c:1776:1003/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80OTY5MDc4MzcxMl8yYTc1ZmQ5M2MyX28uanBn.webp" /></div></figure><p>The pharma giant is betting that Blueprint, whose research&nbsp;revolves around a certain kind of tyrosine kinase, will be a boost to its immunology business.</p>